Document is current
Any future updates will be listed below
-
Authors
Bekliz, Meriem https://orcid.org/0000-0003-3186-1877
Adea, Kenneth
Vetter, Pauline
Eberhardt, Christiane S.
Hosszu-Fellous, Krisztina
Vu, Diem-Lan
Puhach, Olha https://orcid.org/0000-0002-5789-8988
Essaidi-Laziosi, Manel
Waldvogel-Abramowski, Sophie
Stephan, Caroline
L’Huillier, Arnaud G.
Siegrist, Claire-Anne https://orcid.org/0000-0001-7984-8669
Didierlaurent, Arnaud M.
Kaiser, Laurent https://orcid.org/0000-0002-0857-2252
Meyer, Benjamin https://orcid.org/0000-0003-0601-3550
Eckerle, Isabella https://orcid.org/0000-0002-4850-7172
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (196644)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (196383)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (198412)
Fondation Ancrage Bienfaisance du Groupe Pictet Fondation Privée des Hôpitaux Universitaires de Genève.
- License Information
-
More Information
Article History
Received: 21 January 2022
Accepted: 22 June 2022
First Online: 4 July 2022
Competing interests
: Financial: A.D. is a consultant for Speranza, Non-financial: Chairman for WHO Technical Advisory Group (TAG) on Emergency Use Listing of COVID-19 vaccines. All other authors declare no competing interests.
